Stronger Plan Governance. Lower Fiduciary Risk.
Helping employers take control of fiduciary oversight for their health care plans.
Welcome to
Greenleaf Advisors
ERISA has always governed both retirement plans and health & welfare plans.
Yet while most employers have established strong fiduciary practices on the retirement side, the same level of governance has not carried over to their health plans.
Today, that gap carries real risk.
New regulations—including the Consolidated Appropriations Act of 2021 (CAA 2021), Hospital Pricing Transparency, and Transparency in Coverage—are finally shining a light on the traditionally opaque healthcare ecosystem. With that transparency, however, comes greater complexity and new expectations for employers:
- Understanding plan designs, vendor contracts, and compensation
- Evaluating fees and services for reasonableness
- Monitoring performance and conflicts of interest
- Ensuring every decision aligns with fiduciary duties
Most employers simply don’t have the bandwidth or expertise to keep up.
About US
With 30+ years of experience in fiduciary governance, we sit on the same side of the table as the employer. We are independent, unbiased, and pragmatic—focused solely on helping employers fulfill their fiduciary obligations and strengthen their governance process.
We do the heavy lifting so you can confidently demonstrate a prudent, well-documented, and defensible fiduciary process.

Our Services

Comprehensive Risk Audit
Get a clear view of where your health plan may be exposed - and where savings may be hiding. Our Comprehensive Risk Audit reviews plan operations, pricing transparency requirements, compensation structures, and compliance risk so you can make confident, fiduciary-aligned decisions in today’s increasingly regulated environment.
Read More
Fiduciary Governance & Structure Setup
A strong fiduciary process doesn’t happen by accident - it’s built. We help employers establish a formal ERISA fiduciary governance framework with the structure, documentation, and education needed to support consistent oversight, clear accountability, and defensible decision-making.
Read More
Fiduciary Oversight & Risk Mitigation
Plan management isn’t “set it and forget it.” We help you move from review to ongoing fiduciary oversight with continuous monitoring, vendor accountability, and data-driven checks that identify issues early, reduce exposure, control costs, and support long-term compliance.
Read More
Fiduciary Governance
For Today’s Benefit Plans
Greenleaf Advisors helps employers reduce fiduciary liability and strengthen oversight across health & welfare plans—an area that has quietly become one of the largest sources of cost and risk for organizations.
Health plans now represent a top-three employer expense, yet they often deliver diminishing value while exposing employers—and the individuals responsible for plan decisions—to increasing legal and fiduciary risk. Despite the size and significance of these plans, they are frequently managed through opaque contracts, withheld data, and conflicted intermediaries, leaving employers without clear visibility or control.
You cannot govern what you cannot see.
The first step in understanding both your exposure and opportunity is gaining clarity on:
- Where your health plan dollars actually go
- Who profits from your plan and how
- How decisions are being made—and whether they align with fiduciary obligations
Without this information, true oversight is impossible.
That’s why we start with a Comprehensive Risk Audit.
This audit provides employers with a clear picture of where fiduciary and compliance exposures exist today, while creating a practical roadmap to transparency, governance, and cost control—so you can regain control with confidence.
Pbm Contract Fiduciary Analysis
PBM contract fiduciary analysis is a structured review of your pharmacy benefit manager agreement designed to protect you from hidden costs, regulatory exposure, and fiduciary liability. Greenleaf Advisors helps mid-to-large employers across Florida and nationally examine the terms, pricing transparency, and vendor accountability built into their PBM relationships so you can make defensible decisions about one of your health plan's largest expenses.
The Problem: PBM Contracts Hide Real Costs
Most employers sign PBM contracts without genuinely understanding what they are paying for or what they have given up. Pharmacy benefit managers operate in an intentionally opaque industry where spread pricing, rebate clawbacks, and formulary restrictions can quietly inflate your total plan costs by 10 to 20 percent or more. When audit rights are weak, performance guarantees are vague, or fee structures are buried in appendices, your fiduciary responsibility becomes very difficult to prove-and your exposure to regulatory challenge becomes real.
Plan sponsors and benefits managers in Florida and beyond tell us the same thing: they inherited their PBM contracts, they don't have the expertise to challenge vendor terms, and they worry about getting locked into unfavorable arrangements with no clear way to measure whether they are receiving fair value. Because your fiduciary duty requires you to act in the interest of your plan and its participants, ignoring these gaps is not a neutral choice-it is a documented failure of governance.
Our Approach to PBM Contract Fiduciary Analysis
Greenleaf Advisors brings 30+ years of ERISA compliance and fiduciary governance experience to a detailed, defensible review of your PBM contract. We are independent-we have no relationship with any pharmacy benefit manager or pharmacy network-so our analysis is unbiased and focused entirely on your plan's interests.
Here is how we structure this work:
- Contract term mapping. We read your actual agreement and identify audit rights, termination clauses, rebate passthrough language, and performance obligations. Most employers have never done this thoroughly.
- Pricing transparency assessment. We analyze your fee structure against current market practices to identify whether you are paying competitive rates and whether costs are clearly visible and measurable.
- Vendor accountability framework. We document what you should require from your PBM in writing, including data access, formulary justification, generic substitution rates, and claims handling timeliness.
- Fiduciary defensibility. We prepare documentation showing that your plan sponsor has exercised prudent oversight and acted with independent judgment. This is your shield if regulators or plan participants ever question your vendor decisions.
- Renegotiation roadmap. If gaps exist, we outline specific contract amendments or performance expectations you can require in your next renewal or managed care review.
What This Analysis Reveals
When Greenleaf Advisors completes a fiduciary analysis of your PBM relationship, you receive a clear-eyed assessment of your actual costs and risks. Plan sponsors typically discover one or more of the following:
- Spread pricing arrangements where the PBM retains undisclosed margin between what it pays pharmacies and what it bills your plan.
- Rebate structures that do not flow back to your plan or that are used to offset fees in ways that obscure true net cost.
- Limited audit or data access rights, making it impossible to verify claims accuracy or formulary compliance.
- Weak or missing performance guarantees tied to generic utilization, mail-order penetration, or cost containment benchmarks.
- Termination penalties or lock-in provisions that make it costly or impractical to switch vendors even if you identify a better option.
Because these findings are documented in a formal fiduciary analysis, you have a clear record of what you know, when you knew it, and what actions you took in response. This documentation is essential to fiduciary governance and compliance monitoring, and it demonstrates to regulators and auditors that your plan sponsor exercised prudent judgment.
Real Outcomes: How This Protects Your Plan
Plan sponsors who engage in a structured PBM contract fiduciary analysis typically achieve measurable outcomes. Employers have renegotiated contracts based on our findings, recovering 5 to 8 percent in annual pharmacy spend through improved transparency and more competitive pricing. Others have established vendor scorecards and quarterly review meetings to monitor PBM performance year-round, shifting from passive acceptance to active governance. Still others have simplified their fee structures, moving from opaque spread pricing to transparent pass-through models where they can see and control every dollar.
Beyond cost, the fiduciary benefit is equally important. When you conduct this analysis, you create a documented record that your plan sponsor has fulfilled its duty of prudent oversight. You establish vendor accountability expectations. You clarify what data and reporting your plan is entitled to receive. And you position your organization to defend its healthcare benefits decisions against any future regulatory inquiry or participant lawsuit.
Taking Your Next Step
If you oversee a health plan with self-insured or fully-insured pharmacy coverage, and you have never conducted a formal fiduciary analysis of your PBM contract, now is the time. The healthcare regulatory environment continues to tighten, and plan sponsors face increasing scrutiny around vendor selection and ongoing oversight. A structured review positions you as a prudent fiduciary and gives you the information you need to negotiate from strength.
Greenleaf Advisors is ready to help. We work with benefits managers, plan sponsors, and HR executives across Florida and nationwide to assess PBM relationships and establish defensible fiduciary governance. If you would like to discuss your current PBM arrangement or explore what a fiduciary analysis might reveal about your pharmacy costs and contract terms, reach out to us. We are here to guide you through the process and help you strengthen your plan's oversight and compliance posture.
Frequently Asked Questions
What is the difference between a PBM audit and a fiduciary analysis?
A PBM audit is a compliance review of claims data and pharmacy network pricing conducted by the plan or a third party to check for billing errors. A fiduciary analysis is a broader assessment of your contract terms, fee structures, vendor accountability, and governance practices to ensure your plan sponsor has exercised prudent oversight. Fiduciary analysis often informs what you should audit for.
How often should we conduct a fiduciary analysis of our PBM contract?
Best practice is to conduct a comprehensive fiduciary analysis every three to five years or whenever your PBM contract renews. You should also review your PBM relationship annually as part of ongoing fiduciary oversight and compliance monitoring to ensure performance meets your expectations and costs remain competitive.
What does it cost to have a professional fiduciary analysis of our PBM contract?
Cost varies based on plan size, contract complexity, and the scope of analysis. We recommend contacting Greenleaf Advisors directly for a consultation and proposal tailored to your situation.
Can a fiduciary analysis help us reduce our pharmacy costs?
Yes. By identifying opaque pricing, weak performance guarantees, and unfavorable contract terms, a fiduciary analysis often uncovers opportunities to renegotiate better rates, simplify fee structures, or establish vendor accountability benchmarks. Many plan sponsors recover 5 to 8 percent of annual pharmacy spend through findings and recommendations from this type of review.
Do we need a fiduciary analysis if we already have a benefits consultant?
It depends. If your current consultant specializes in ERISA compliance and fiduciary governance and conducts an annual formal review of your PBM contract terms and pricing, you may have coverage. However, many traditional benefits consultants focus on plan design and renewal shopping rather than deep fiduciary analysis of vendor accountability and contract language. Greenleaf Advisors specializes in the fiduciary governance and risk mitigation side, and we often complement existing consultant relationships.

DID YOU KNOW
Employers have a legal obligation to act in the sole interest of plan participants.
Between 15% and 25% of health care dollars are consumed by administrative expenses, totaling hundreds of billions of dollars each year.
Employer cost-reduction efforts are often undermined by intermediary incentives that are not aligned with plan sponsor interests.
